News from CeQur SA A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

01 Sep, 2015, 07:00 ET CeQur annonce un financement de série C de 100 millions d'USD

-- Les fonds vont permettre de poursuivre les activités cliniques et réglementaires ainsi que la commercialisation du premier dispositif...


01 Sep, 2015, 07:00 ET CeQur gibt Finanzierungsrunde Serie C im Umfang von 100 Mio. US-Dollar bekannt

-- Diese Geldmittel tragen sowohl zur Finanzierung der laufenden klinischen und regulatorischen Aktivitäten als auch zum kommerziellen...


10 Apr, 2014, 19:38 ET CeQur® désigne Douglas Lawrence au poste de président directeur général

 – Fort de son expérience en matière de dispositifs médicaux, ce cadre mènera la société en direction de...


08 Jan, 2014, 12:01 ET CeQur participera à la 32e édition de la Conférence annuelle JP Morgan sur les soins de santé (« JP Morgan Healthcare Conference »)

La société CeQur® SA, leader des systèmes simples d'injection d'insuline destinés aux personnes souffrant de diabète...


08 Jan, 2014, 08:00 ET CeQur to Present at the 32nd Annual J.P. Morgan Healthcare Conference

 CeQur® SA, a leader in simple insulin infusion for people with type 2 diabetes, today announced that the company has been invited to...


24 Sep, 2013, 13:49 ET Beneficios potenciales del sencillo dispositivo de suministro de insulina presentado en el Encuentro Anual de la EASD

- Los datos demuestran los beneficios potenciales del sencillo dispositivo de suministro de insulina presentado en el Encuentro Anual de la...


24 Sep, 2013, 13:39 ET Die auf dem jährlichen Treffen der European Association for the Study of Diabetes präsentierten Daten zeigen die potenziellen Vorteile des Infusionsgeräts für die einfache Insulinvergabe

- Daten legen nahe, dass PaQ® Patienten mit Typ-2-Diabetes eine bessere glykämische Kontrolle ermöglicht CeQur® SA, ein...


09 Sep, 2013, 08:05 ET CeQur SA Closes $27 Million Series B Financing

 CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the closing of a $27...


22 Jun, 2013, 11:31 ET New Data Demonstrate Simple Insulin Delivery Device Can Significantly Reduce Barriers to Insulin Treatment Among People with Type 2 Diabetes

CeQur® SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that comprehensive data...


28 Feb, 2013, 12:09 ET CeQur Announces Positive Results from Study Evaluating Simple Insulin Delivery Device Among People with Type 2 Diabetes

CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that initial data from a study...


11 Dec, 2012, 08:00 ET CeQur Appoints Michael Trautmann, MD Medical Director for Anti-Diabetic Peptides

 CeQur SA, a company focused on the development and commercialization of simple delivery devices for diabetes, announced the appointment of...


27 Nov, 2012, 08:00 ET CeQur Receives CE Mark for PaQ® Insulin Delivery Device

 CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that the PaQ® Insulin...


26 Sep, 2012, 11:07 ET CeQur Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People with Type 2 Diabetes

 CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the completion of a...


06 Jun, 2012, 05:00 ET CeQur SA Initiates Clinical Study of Simple Insulin Delivery Device for People with Type 2 Diabetes

 CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the initiation of a...


13 Apr, 2010, 08:00 ET CeQur SA Names Robert O'Holla EVP for Regulatory Affairs

CeQur SA, a company focused on the development and commercialization of insulin delivery systems to improve the management of type 2 diabetes,...


05 Jan, 2010, 08:00 ET CeQur SA Completes Series A Investment With 10 Million Dollar Raise in December 2009

CeQur SA, a company focused on the development and commercialization of insulin delivery systems to improve the management of type 2...


06 Oct, 2009, 08:58 ET CeQur SA Appoints Eric Milledge Chairman of the Board of Directors

CeQur SA, a company focused on the development and commercialization of insulin delivery systems to improve the management of type 2...